Spermidine Associated to Non-Surgical Treatment of Periodontal Disease: Split Mouth Randomized Controlled Clinical Trial

Objectives. Spermidine is an endogenous polyamine whose increase induces the autocrine remodeling into targeted cells. The aim of the present study was to evaluate the adjunctive beneficial effects of the local delivery of spermidine to periodontal non-surgical therapy on reduction of periodontal pocket. Methods. In this split mouth, blind, randomized controlled clinical trial, 20 patients with severe chronic generalized periodontal disease scheduled for cause related non-surgical periodontal treatment were enrolled. In three quadrants for each patients, three experimental teeth with probing pocket depth (PPD) 65 6mm were selected and randomly assigned to one of the following treatments: scaling and root planning (SRP)+ spermidine gel (spermidine + alginate) (group a), SRP+ placebo gel (only alginate) (positive control, group b) or SRP (negative control, group c). PPD at baseline, 3 and 6 months after treatment was assessed. Descriptive and inferential statistics was done. Results. After periodontal treatment, a reduction of PPD was observed in all sites. No differences emerged between groups at each time point. In all groups, a significant PPD reduction was observed at T1 and T2 compared to baseline (p<0.05 and p<0.001). PPD reduction from T1 to T2 was significant only in group a (p<0.001). Conclusions. After non-surgical treatment, local delivery of spermidine may induce prolonged improvement of clinical outcome